VBWG

7 related results for Progression


A Diabetes Outcome Progression Trial

ADOPT

This resource is not available online, you may order a copy of this data alert if it is in stock.

ADOPT: A Diabetes Outcome Progression Trial

View/Download individual slides (15 Slides)

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section III: Heart failure: The new vascular biology imperative to blunt progression

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Vascular Biology in Clinical Practice © Vol. 4, No. 5

The potential role of beta-blockade in blunting the progression of atherosclerosis

This monograph, The potential role of beta-blockade in blunting the progression of atherosclerosis , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 4, No. 2

Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression

This monograph, Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

SECURE: ACE inhibition retards the progression of atherosclerosis

Final results of the Study to Evaluate Carotid Ultrasound changes with Ramipril and vitamin E (SECURE) have been published and confirm that treatment with ramipril 10 mg slows the progression of atherosclerosis, while treatment with vitamin E has no apparent effect.

Vascular Biology in Clinical Practice © Vol. 1, No. 2

Overview of clinical trials to improve endothelial function

Fundamental views on the progression of cardiovascular disease are evolving toward a clearer understanding that the endothelium plays a central role in health and disease.